Pharmacological action of octopamine with special reference to biochemical conversion to noradrenaline.
D000200:Action Potentials; D000311:Adrenal Glands / Q000032:analysis; D000818:Animals; D001158:Arteries / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects*; D001923:Brain Chemistry; D002395:Catecholamines / Q000378:metabolism; D003042:Cocaine / Q000494:pharmacology; D004285:Dogs; D004837:Epinephrine / Q000032:analysis / Q000494:pharmacology; D005260:Female; D005725:Ganglia, Autonomic / Q000502:physiology; D006651:Histocytochemistry; D066298:In Vitro Techniques; D008297:Male; D009206:Myocardium / Q000378:metabolism; D009541:Nictitating Membrane / Q000502:physiology; D009638:Norepinephrine / Q000032:analysis / Q000378:metabolism*; D009655:Octopamine / Q000378:metabolism / Q000494:pharmacology*; D012110:Reserpine / Q000494:pharmacology; D013154:Spleen / Q000032:analysis / Q000378:metabolism; D013363:Submandibular Gland / Q000032:analysis / Q000378:metabolism; D014043:Tolazoline / Q000494:pharmacology; D014439:Tyramine / Q000494:pharmacology; D014628:Vagotomy
D002395:Catecholamines; D009655:Octopamine; D012110:Reserpine; D014043:Tolazoline; D003042:Cocaine; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine